s 9788 has been researched along with Adenocarcinoma Of Kidney in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Backx, A; Bleiberg, H; De Mulder, PH; Gerard, B; Hecquet, B; Lucas, C; Punt, CJ; Tueni, E; Van Oosterom, AT; Voest, EE | 1 |
1 trial(s) available for s 9788 and Adenocarcinoma Of Kidney
Article | Year |
---|---|
Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Colorectal Neoplasms; Doxorubicin; Drug Resistance, Multiple; Electrocardiography; Heart; Humans; Kidney Neoplasms; Middle Aged; Piperidines; Triazines | 1997 |